發(fā)布時(shí)間：2018-07-24 12:48

【摘要】：黑熱病后皮膚利什曼病(post kala-azar dermal leishmaniasis,PKDL)在印度和蘇丹等國(guó)家的內(nèi)臟利什曼病(黑熱病)流行區(qū)頗為常見,并且是當(dāng)?shù)貎?nèi)臟利什曼病的主要傳染源。PKDL在我國(guó)的發(fā)病人數(shù)雖然不多,但近年來在西部的內(nèi)臟利什曼病流行區(qū)仍有出現(xiàn)。由于PKDL患者的皮膚結(jié)節(jié)酷似瘤型麻風(fēng),極易造成誤診誤治。本文重點(diǎn)介紹了國(guó)內(nèi)外對(duì)PKDL的臨床表現(xiàn)、診斷、治療以及發(fā)病機(jī)制等方面的研究進(jìn)展,同時(shí)也對(duì)PKDL和皮膚利什曼病的鑒別要點(diǎn)作了介紹。希望能對(duì)從事利什曼病和皮膚病的科研和防治人員有所裨益。
[Abstract]:Post kala-azar dermal leishmaniasisPKDL is very common in endemic areas of visceral leishmaniasis in India and Sudan, and is the main infection source of visceral leishmaniasis in China. In recent years, however, visceral leishmaniasis is still present in western endemic areas. Because the skin nodules of PKDL patients are similar to leprosy, misdiagnosis and mistreatment are easy. This article mainly introduces the clinical manifestation, diagnosis, treatment and pathogenesis of PKDL at home and abroad. At the same time, it also introduces the distinguishing points between PKDL and cutaneous leishmaniasis. Hope to be able to engage in leishmaniasis and dermatosis research and prevention and control personnel.
【作者單位】： 中國(guó)疾病預(yù)防控制中心寄生蟲病預(yù)防控制所世界衛(wèi)生組織熱帶病合作中心科技部國(guó)家級(jí)熱帶病國(guó)際聯(lián)合研究中心衛(wèi)生部寄生蟲病原與媒介生物學(xué)重點(diǎn)實(shí)驗(yàn)室;
【分類號(hào)】：R531.6

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊sヌ，

本文編號(hào)：2141437